Brief: Matinas Biopharma reports Q2 results
11/08/2022 11:40
Aug 11 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT PROGRESS
* FOR Q2 , NET LOSS WAS $5.9 MILLION, OR A NET LOSS OF $0.03
PER
SHARE (BASIC AND DILUTED)
Source text for Eikon: ID:nGNX2qQqsr
Further company coverage: MTNB.A
Recent news on Matinas BioPharma Holdings
See all newsBrief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing
Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
Brief: Matinas Biopharma Holdings Inc - CFO Keith Kucinski Resigns Effective January 17, 2026 - SEC Filing
Brief: Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma
Brief: Matinas BioPharma Appoints Seasoned Biotech Leaders To Board Of Directors